Fri.Oct 09, 2020

article thumbnail

Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL

Bio Pharma Dive

The medicine, a concentrated infusion of blood antibodies, is different than the convalescent plasma that was recently cleared for emergency use by the FDA.

Antibody 238
article thumbnail

DTC marketers disconnect from digital marketing

World of DTC Marketing

HERE’S THE PITCH: Guidelines surrounding effective frequency are different by every advertised product. For pharma products, effective frequency is, for example, the frequency at which someone is going to go online to learn more about your product. TV alone is not going to sell your product. You need to invest in digital marketing too. DTC marketers should be joined at the hip with their market research people.

Marketing 139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer stumbles again in early breast cancer study, clearing path for Eli Lilly

Bio Pharma Dive

The latest setback for Pfizer's top-selling Ibrance leaves Lilly's Verzenio, for now, as the only drug in its class to be proven to stave off breast cancer recurrence after surgery.

Drugs 213
article thumbnail

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

pharmaphorum

Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government. The findings came from additional safety and efficacy data harvested from the US National Institute of Allergy and Infectious Diseases’ (NIAID) ACCT-2 trial.

Allergies 111
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Parkinson’s disease is not one, but two diseases

Scienmag

A major study from Aarhus University in Denmark has now identified that there are actually two types of Parkinson’s disease. Credit: Per Borghammer/Jonathan Bjerg Møller (video), Aarhus University Although the name may suggest otherwise, Parkinson’s disease is not one but two diseases, starting either in the brain or in the intestines. Which explains why patients […].

article thumbnail

Flying the flag for research in Aarskog syndrome

pharmaphorum

Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study hopes to kick start a revolution in understanding. For five years, Michelle Erskine faced a succession of closed doors and disbelief as she struggled to convince someone that all was not well with her son.

Research 105

More Trending

article thumbnail

EU ramps up supply of COVID-19 vaccine, drugs

pharmaphorum

The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johnson’s experimental candidate. The agreement is the third for coronavirus vaccine supply for the EU, coming after earlier deals with AstraZeneca and Sanofi/GlaxoSmithKline, and comes as wealthy nations are scrambling to secure access to the initial supplies of the shots furthest ahead in development.

article thumbnail

New patent expiration for Leo Labs drug PICATO

Drug Patent Watch

Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents…. The post New patent expiration for Leo Labs drug PICATO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

UMD researchers use artificial intelligence language tools to decode molecular movements

Scienmag

Algorithms–like the ones that fill in words as people type–can learn to predict how and when proteins form different shapes. Credit: Image credit Zachary Smith/UMD By applying natural language processing tools to the movements of protein molecules, University of Maryland scientists created an abstract language that describes the multiple shapes a protein molecule can take […].

Protein 98
article thumbnail

Neuroblastoma UK welcomes advancement of potential new treatment

Pharma Times

Fadraciclib has passed safety trials and shown early efficacy

Trials 127
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

The Colorado river’s water supply is predictable owing to long-term ocean memory

Scienmag

Scientists develop new tool to forecast drought and water flow in the Colorado river Credit: Photo by Stephen Walker A team of scientists at Utah State University has developed a new tool to forecast drought and water flow in the Colorado River several years in advance. Although the river’s headwaters are in landlocked Wyoming and […].

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Population health and the COVID-19 pandemic: Emerging stronger next time

Scienmag

Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, October 6, 2020—Battling the COVID-19 pandemic and preparing for the inevitable next surge requires a data-driven population health approach. A special issue of the peer-reviewed journal Population Health Management is dedicated to combatting COVID-19. It embraces systems thinking and key insights from other industries.

article thumbnail

Amgen announces NHS collaboration aiming to tackle high cholesterol

Pharma Times

Partnership will aim to prevent cardiovascular events across the North West Coast of England

92
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does

Scienmag

Credit: Layla Aerts – KU Leuven Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent infection, and testing existing drugs to see which one can reduce the amount of virus in infected people. To test the efficacy of the vaccine and antivirals […].

article thumbnail

European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine

Pharma Times

Advance purchase agreement follows initial exploratory talks

article thumbnail

Investing in protective gear for health care workers pays off

Scienmag

Credit: Risko et al, PLOS ONE, 2020 (CC BY) Providing adequate personal protective equipment (PPE) for all health care workers around the world requires an initial investment of billions of dollars, but the returns on that investment could be close to 8000% in productivity gains, according to a new study published this week in the […].

article thumbnail

London universities join forces to ramp up COVID-19 testing

Pharma Times

Testing Alliance created to offer 20,500 extra coronavirus tests a day

91
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Professor Simon Pollard awarded OBE for services to the environment

Scienmag

Cranfield University Professor awarded OBE for services to environmental risk management Credit: Cranfield University Professor Simon Pollard DSc FREng, Pro-Vice-Chancellor of Cranfield University, has been awarded an OBE in the Queen’s Birthday Honour’s list 2020 for services to environmental risk management. Professor Sir Peter Gregson, Cranfield’s Chief Executive and Vice-Chancellor said, “Simon’s leading work on […].

article thumbnail

Trump’s Testimonial Is a Double-Edged Sword for Regeneron

NY Times

The president raised the drug’s company’s profile by calling its drug a miraculous cure — but also sowed suspicion about whether the treatment really works.

Drugs 60
article thumbnail

Droughts are threatening global wetlands: new study

Scienmag

Credit: Luke Mosley University of Adelaide scientists have shown how droughts are threatening the health of wetlands globally. Published in the journal Earth-Science Reviews, the scientists highlight the many physical and chemical changes occurring during droughts that lead to severe, and sometimes irreversible, drying of wetland soils. “Wetlands around the world are incredibly important for […].

article thumbnail

China signs up to WHO supported global COVID-19 vaccine program

BioPharma Reporter

China has joined the global effort called COVAX to ensure equitable global access to COVID-19 vaccines.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Most nations failing to protect nature in COVID-19 pandemic recovery plans

Scienmag

Outbreak provides opportunity to reset economy and reverse ecosystem, species losses Credit: Pamela McElwee The COVID-19 pandemic provides an opportunity to reset the global economy and reverse decades of ecosystem and species losses, but most countries are failing to invest in nature-related economic reforms or investments, according to a Rutgers-led paper.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Interactive publication explores French theater during the Enlightenment and Revolution

Scienmag

Innovative, open access volume opens new avenues of inquiry and broadens the nature of humanities scholarship Credit: Image created by Laetitia Gendre CAMBRIDGE, MA — The MIT Press announced today the publication of Databases, Revenues and Repertory: The French Stage Online, 1680-1793 an innovative collection of original essays that explore an important initiative in the […].

81
article thumbnail

VirTrial Selected for COVID-19 Phase 2 Decentralized Clinical Trial

VirTrial

Scottsdale, AZ (October 09, 2020) – VirTrial today announced its selection by BetterLIfe Pharma Inc. (CSE: BETR / OTCQB: BETRF) as their telehealth platform provider of choice. The partnership will enable BetterLife to conduct remote patient monitoring for their imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation. .

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

‘Yeshiva Days’ records Lower East Side Jewish life

Scienmag

ITHACA, N.Y. – In 2012, Jonathan Boyarin, professor of modern Jewish studies at Cornell University, spent a year of academic leave studying Torah at Mesivtha Tifereth Jerusalem (MTJ), New York’s oldest institution of rabbinic learning. He describes his experience in “Yeshiva Days: Learning on the Lower East Side.” Part ethnography, part memoir, the book portrays […].

75
article thumbnail

Discriminatory Reimbursement Practices by PBMs Represent a Threat to Public Health: A Perspective from Community Health

Drug Channels

Today’s guest post comes from Shannon Stephenson, CEO of Cempa Community Care. I am publishing this opinion piece to share a perspective from a community health provider that is eligible for the 340B Drug Pricing Program as a Ryan White clinic and as a Federally Qualified Health Center Look-Alike. As I noted last week in my September news roundup , I generally consider federal grantees to be the good guys of 340B.

article thumbnail

Effects of poverty on childhood development seen in children as young as 5

Scienmag

How kindergarten teachers helped UCLA researchers highlight the impact of socioeconomic barriers on children’s health and development. In a nationwide study, UCLA researchers have found that health inequities can be measured in children as young as 5 years old. The research, published in Health Affairs, contributes to a growing body of literature finding that children […].

article thumbnail

NHS digital triage provider to expand with £5m investment

pharmaphorum

Equity investor Gresham House has invested £5m into the NHS’s digital triage provider eConsult Health, allowing the service to expand to meet demand during the COVID-19 pandemic. eConsult provides online consultation services to NHS primary care organisations and will use the investment to maintain its position as a provider in GP surgeries. COVID-19 has showed the need for tools to relieve pressure on surgeries.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.